Address |
1 Evertrust Plaza Jersey City New Jersey 07302 United States |
Employees | - |
Website | http://www.scynexis.com |
Updated | 07/08/2019 |
SCYNEXIS, Inc. engages in the development and commercialization of novel anti-infectives, which addresses the significant unmet therapeutic needs. It develops a novel oral and intravenous drug for several fungal infections, including serious and life-threatening invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. |